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Edited by Judit OvadiAbstract The Ca2+-free form of calmodulin (CaM), apocal-
modulin (ApoCaM), regulates a variety of target proteins
including nitric oxide synthase II (NOS-II). The CaM-binding
site of NOS-II can bind ApoCaM with high aﬃnity. Substitution
of hydrophobic amino acids by charged amino acids at crucial
positions 3, 9 and 13 within the CaM-binding motif did not
abolish the ApoCaM interaction that occurred with signiﬁcant
aﬃnity, though the aﬃnity of the interaction was decreased
remarkably. Isothermal titration calorimetry revealed that
interaction of ApoCaM and synthetic NOS-II peptides was
driven entropically.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Cellular Ca2þ-signals are monitored by Ca2þ-sensor proteins
that transduce the signal to a corresponding target protein.
The ubiquitous sensor calmodulin (CaM) controls a variety of
target proteins and thereby regulates many cellular processes
[1–3]. However, CaM not only operates as a modulator of cell
signaling in its Ca2þ-bound form: the Ca2þ-free form, denoted
apocalmodulin (ApoCaM), but is also able to regulate the
function of speciﬁc target proteins [3]. A prominent example of
an ApoCaM target is the inducible nitric oxide synthase (NOS-
II), which binds CaM with high aﬃnity and is active in the
absence of Ca2þ [4].
All NOS isoforms harbor a CaM-binding site that ﬁts well
into the sequence motif of a classical Ca2þ-CaM-binding site,
i.e., they consist of approximately 20 amino acids that form an
amphipathic a-helix. Hydrophobic amino acid residues are* Corresponding author. Fax: +49-2461-614216.
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0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.10.048mainly found at the positions 1-8-14 or 1-5-10. It is noteworthy
that the Ca2þ-independent interaction of CaM with NOS-II
occurs at a CaM-binding site that does not correspond to the
IQ motif (IQxxxRGxxxR), a typical ApoCaM binding motif
found in many CaM regulated proteins [2,3].
In a recent peptide binding study, we identiﬁed critical
amino acid substitutions in the 1-8-14 motif of NOS-I that
convert the classical Ca2þ-CaM-binding site into a site for
ApoCaM-binding [5]. Substitutions were inspired by a com-
parison of NOS-I and NOS-II CaM-binding sites. For exam-
ple, substitution of a negative charge to a positive charge is
suﬃcient to create a target site for ApoCaM, further intro-
duction of hydrophobic amino acids increases the apparent
aﬃnity for ApoCaM by almost one order of magnitude. Based
on these observations, we reasoned that corresponding sub-
stitutions in the (Apo)CaM-binding site of NOS-II could either
decrease the aﬃnity for ApoCaM or even disable any Apo-
CaM binding. Therefore, we designed peptides with the cor-
responding amino acid exchanges and studied their ApoCaM
binding characteristics.2. Materials and methods
2.1. Peptide synthesis
Peptides were synthesized, puriﬁed and characterized as described
[6]. Purity was P 95% by HPLC analysis. Concentration of peptides
was determined by measuring the absorption of the peptide bond at
205 nm using the formula c ðmg ml1Þ ¼ A205d=e, where d is 1 cm and
e is 31 [7].
2.2. Isothermal titration calorimetry (ITC)
Principles of experimental design and theory of data analysis of ITC
has been described [8,9]. The experimental steps were performed as
described for NOS-I peptides [5]. Brieﬂy, the VP-ITC MicroCalorim-
eter from MicroCal Incorporated (kindly provided by Prof. M. Bott,
IBT, Forschungszentrum J€ulich) consists of a sample cell, a reference
cell and a spinning syringe. One binding partner was placed in the
sample cell and the other (reactant) in the spinning syringe. The cal-
orimeter determines the temperature diﬀerence between the sample cell
and the reference cell, when the reactant is injected into the sample cell.
The binding enthalpy and the equilibrium constant can be derived
from a titration experiment, where the concentration of one binding
partner is kept constant in the sample cell and the concentration of the
reactant is increased by repetitive injections. Peptides and CaM were
dissolved in water and diluted in buﬀer to a ﬁnal concentration of 200
lM and 8 lM, respectively. Titration steps were 0.5 or 1 nmol per
injection. The buﬀer contained 10 mMHEPES, pH 7.4, 150 mMNaCl,
2 mM MgCl2, 10 mM EGTA and 0.005% (v/v) Tween 20 (EGTA-
buﬀer). All measurements were done at 25 C. Data analysis was done
with Microcal Origin Version 5.0 as described [5,8,9].ation of European Biochemical Societies.
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CaM stock solutions were prepared from a lyophilized powder
purchased from Sigma. Protein concentration was determined by a
Coomassie Blue dye binding assay [10] using a CaM standard curve.
The concentration of CaM standards were adjusted by using the molar
extinction coeﬃcient of CaM at 277 nm of e ¼ 3006 M1 cm1. Al-
ternatively, the BCA Protein Assay Reagent Kit of Pierce was used as
described previously [5].
2.4. Fluorescence measurements
CaM was derivatized with dansyl-chloride (dansyl, 5-(dimethyla-
mino)naphthalene-1-sulfonyl) according to a published procedure [11]
with some modiﬁcations as described [5]. Fluorescence experiments
were performed similarly as described [5,11] using a Shimadzu RS-1501
ﬂuorescence spectrometer. Excitation wavelength was at 335 nm, the
emission spectrum was recorded from 420 to 650 nm. Dansyl-CaM (1
lM) was ﬁrst measured in buﬀer without calcium in the absence of
peptides. Afterwards, measurements were done in the presence of
varying peptide concentrations. Titration with peptides was performed
in 0.5 or 1 lmol L1 steps until the signal reached saturation. Con-
centration of free Ca2þ in EGTA containing buﬀer solution after ad-
dition of peptides was checked via determination of ﬂuorescence
lifetime with the Ca2þ-indicator calcium green 1 [12]. The free Ca2þ in
EGTA-buﬀered solutions was <50 nM and did not change after ad-
dition of peptides.511  514  517    521 
NOS-II WT 503 528
NOS-II V511K
NOS-II F517K
NOS-II M521K
NOS-II 3K
NOS-II E3K
 1   5     8  10  14 
Fig. 2. Amino acid sequences of the peptides used in this study. At
critical positions (511, 514, 517, 521; gray boxes), amino acids are
changed to the corresponding residues present in NOS-I. Positions 1-5-
8-10-14 of classical CaM-binding motifs are indicated (bold letters and
small arrows). Vertical lines mark the boundaries of the corresponding
helical wheel diagram in Fig. 1.3. Results
3.1. Binding of mutant peptides to ApoCaM monitored by
changes in ﬂuorescence emission
The CaM-binding site of mouse macrophage NOS-II (aa
503–528) consists mainly of hydrophobic amino acids. When
displayed in a helical wheel plot (Fig. 1A), it is immediately
apparent that the motif does not represent a typical amphi-
pathic helix as it is found in the CaM-binding site of NOS-I or
other classical Ca2þ-CaM-binding sites [2,3]. We showed pre-
viously that amino acid positions K733, E736, K739 and K743
in NOS-I from rat determine binding ability and aﬃnity to
ApoCaM [5]. Corresponding positions in the NOS-II CaM-
binding site are V511, K514, F517 and M521 (Fig. 2). Sub-
stitutions of these amino acids by the amino acids present in
NOS-I increased the amphipathic character of the binding site
(Fig. 1B). We used synthetic peptides of the indicated se- F 
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Fig. 1. a-Helical wheel diagram of the CaM-binding site of mouse macroph
lighted by gray boxes. (A) WT NOS-II. (B) Mutant NOS-II E3K. Amino aci
more amphipathic mutant peptide. Amphipathic character is highlighted byquences (Fig. 2) to investigate whether the introduced muta-
tions alter ApoCaM binding properties.
First, we tested whether peptides had lost or retained the
ability to interact with ApoCaM. Dansyl-CaM was employed
in ﬂuorescence measurements to study interaction of ApoCaM
with target peptides. Dansyl-CaM in a Ca2þ-free buﬀer has a
maximum of ﬂuorescence emission at 530 nm (Fig. 3A and B).
Addition of equimolar amounts of WT NOS-II peptide shifted
the maximum emission wavelength to 506 nm and increased
the ﬂuorescence intensity by 1.6-fold (Fig. 3A) as reported
previously [5]. Addition of mutant peptides caused a similar
shift of the maximum emission wavelength to 500 nm (all
peptides) and similar increase of the ﬂuorescence intensity like
1.8-fold for NOS-II M521K, 1.9-fold for NOS-II V511K, 1.6-
fold for NOS-II F517K, 1.7-fold for NOS-II 3K and 1.8-fold
for NOS-II E3K (Fig. 3A and B). These experiments showed
that all peptides carrying the substitutions bound ApoCaM.
3.2. Isothermal titration calorimetry
Second, we analyzed the thermodynamics of these target
peptide interactions by isothermal titration calorimetry. A
representative titration in Ca2þ-free buﬀer is shown in Fig. 4.
CaM was present in the sample cell in Ca2þ-free buﬀer, 0.5 orK
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d substitutions (see text) convert the hydrophobic WT peptide into the
the dashed line.
Fig. 4. ITC experiment with peptide NOS-II F517K and ApoCaM.
Upper part: repetitive injections of NOS-II F517K into a solution of 8
lM ApoCaM caused endothermic heat pulses. Lower part: changes in
enthalpy (kcal mol1 of injectant) of the corresponding injections
shown above as a function of the molar peptide to ApoCaM ratio.
Data were ﬁtted by the following equation (Q is the heat absorbed or
evolved; V0 is the volume of reaction cell; Xt is the total concentration
of ligand; K is the binding constant KA;Mt is the total concentration of
macromolecules in cell; n is the number of binding sites)
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A detailed description of data analysis has been given [8,9]. The ti-
tration series above resulted in the following parameter:
KA ¼ 5:041 106 M1, KD ¼ 198 nM, DH ¼ 11:42 kJ mol1,
DS ¼ 68:96 J mol1 K1.
Fig. 3. Fluorescence emission spectra of dansyl-ApoCaM in the ab-
sence and presence of NOS-II peptides. Recording of 1 lM dansyl-
ApoCaM alone (lower traces in A and B) and in the presence of
equimolar amounts of either WT NOS-II, NOS-II M521K or NOS-II
V511K (A) or equimolar amounts of either NOS-II F517K, NOS-II
3K or NOS-II E3K (B).
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injected. Binding of CaM to this peptide caused endothermic
heat pulses that decreased to a stable baseline when saturation
was achieved (Fig. 4, upper part). When all peptides were
analyzed in the same manner, we registered that amino acid
substitutions caused a decrease in aﬃnity in the following
order:
NOS-II M521K > NOS-II F517K > NOS-II V511K >
NOS-II E3K > NOS-II 3K (for KD values see Table 1).
Change in KD from NOS-II M521K to NOS-II 3K was 25-
fold. Interaction of ApoCaM with WT NOS-II peptides was of
similar aﬃnity as the interaction of NOS-II M521K with
ApoCaM (KD  40 nM as reported in [13,14] for WT NOS-II
and KD ¼ 66:8 nM for NOS-II M521K). We also tried to
measure binding of ApoCaM to WT NOS-II peptides (mouse
macrophage and human hepatic types) by ITC. However, due
to the tendency of these peptides to aggregate soon after sol-
ubilization, we were unable to record reliable ITC titration
series.
All binding events employing mutant peptides were endo-
thermic with positive DH values (between 12 and 33 kJTable 1
Thermodynamics of ApoCaM–peptide interaction
Peptide KA (M1) KD (nM) DH (
NOS-II V511K 1:3 106  2:0 105 804 124 25.9
NOS-II F517K 4:4 106  6:4 105 232 33.7 31.2
NOS-II M521K 1:9 107  9:0 106 66.8 31.2 11.9
NOS-II 3K 6:0 105  1:1 105 1660 295 33.3
NOS-II E3K 8:3 105  7:0 104 1199 101 27.0mol1) and positive entropy (between 178 and 232 J mol1
K1) resulting in a negative value of the Gibbs free energy
(for a complete summary of data see Table 1). Thus, positive
values of DH are compensated by large positive values of DS.
Conversion of the hydrophobic NOS-II CaM-binding site
into a site that displays a more amphipathic character
(Fig. 1) did not abolish the principal ability to bind Apo-
CaM, but it changed signiﬁcantly the apparent aﬃnity of
interaction.kJ mol1) DS (J mol1 K1) DG (kJ mol1) n
0.65 203.5 3.4 )34.8 2
1.6 231.6 56.9 )37.9 2
1.3 178.3 8.6 )41.3 2
1.0 222.5 62.5 )33.0 3
9.6 203.9 31.4 )33.7 2
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The diﬀerent hydrophobic character of CaM-binding sites of
NOS isoforms have been recognized for several years, but it is
an unresolved issue as to how these diﬀerences determine the
target recognition by CaM. Structural elucidation of CaM/
target peptide complexes has unravelled an unexpected variety
of three-dimensional conformations (see [1] for recent review)
making it diﬃcult to assign a general model of CaM/target
interaction. The unique versatility of CaM as Ca2þ-sensor and
signaling protein is also evident from observations that Apo-
CaM can bind to and control the activity of many proteins.
Using the CaM-binding site of NOS-II as model for ApoCaM
binding, we here show that the successive exchange of hydro-
phobic amino acids to charged amino acids (K and E) led to a
decrease of apparent aﬃnity without loss of ApoCaM binding
ability. The binding event was entropically driven meaning
that the driving force for binding was the translocation of
solvent exposed hydrophobic side chains to a less water-
exposed environment. A similar conclusion was derived for the
interaction of NOS-I mutant peptides with ApoCaM, where
the positive enthalpic term was also compensated by a larger
entropic term [5]. Furthermore, successive exchange of charged
amino acids to hydrophobic ones in a NOS-I peptide increased
the aﬃnity to ApoCaM, whereas the replacement of hydro-
phobic amino acids by charged amino acids decreased the
aﬃnity.
All NOS isoforms contain the classical ‘1-8-14’ CaM-bind-
ing sequence motif harboring the key hydrophobic residues for
CaM interaction. Aoyagi et al. [15] proposed in a recent study
that hydrophobic residues V517 and L523 (human NOS-II)
might represent additional important hydrophobic anchors for
interaction with ApoCaM. The corresponding amino acids in
our study are V511 and F517 (mouse NOS-II). Indeed, con-
version of these hydrophobic into charged residues decreased
the aﬃnity of the peptides for ApoCaM signiﬁcantly, but it did
not disable binding to ApoCaM. The simultaneous introduc-
tion of three charged amino acids (3K) further weakened the
binding to ApoCaM, but it did not prevent it. Interestingly,
the K514E conversion of a positive to a negative charge at
position 6 did not change much the aﬃnity and the thermo-
dynamic data when NOS-II E3K is compared with NOS-II 3K
(Table 1). When we investigated a NOS-II mutant peptide with
a K>E conversion at position 6 but no other mutations (NOS-
II K514E), we observed no binding to ApoCaM at all (data
not shown). Thus, a positive charge at this position appears to
be important for interaction with ApoCaM consistent with our
previous study on peptide NOS-I E736K [5]. However, a lack
of a positive charge at position 6 can be compensated by a
positive charge at position 13 (for example, in peptide NOS-IIE3K), which might be explained by the spatial proximity of
these two positions according to the helical wheel presentation
(Fig. 1B). Thus, position 6 seems to be important for binding
of a peptide to ApoCaM per se, but it is less important for the
aﬃnity of this interaction.
The site M521 (position 13) also appeared to be less cru-
cial, since the mutant peptide NOS-II M521K retained the
high aﬃnity of WT NOS-II for ApoCaM. This is consistent
with the fact that position 13 varies among all NOS isoforms
[15] and therefore does not require a hydrophobic amino
acid.
Our results are complementary to our previous observations
made with NOS-I peptides [5] and demonstrate the importance
of hydrophobic residues at positions 3, 9 and 13 for ApoCaM
aﬃnity and of position 6 for ApoCaM recognition. Further-
more, interaction of targets with ApoCaM can be ﬁne-tuned
by modiﬁcations at these positions leading to distinct aﬃnities.
Finally, the interaction of all studied peptides (NOS-I and
NOS-II) with ApoCaM is entropically driven.
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